Tori Rodriguez, MA, LPC

In chronic migraine and medication overuse, those who frequently relapse into overuse after withdrawal have a worse clinical and psychological profile than patients who relapse less frequently.

Learn more about what to expect from this year’s International Congress of Parkinson’s Disease and Movement Disorders.

There is up to a 4-fold increase in risk in people with a first-degree relative affected by migraines, and twin studies have demonstrated heritability of approximately 42%.

As many as 80% of patients with migraine experience photophobia, which can occur during or between attacks.

Several mechanisms involving trigeminovascular activation are often proposed in the literature as mechanisms underlying nonhemorrhagic headache in patients with AVM.

Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.

Avoidance can lead to headache disability by reducing pain thresholds and preventing pain habituation.

The characteristics of migraine may change throughout a woman’s reproductive stages, and may require different treatment strategies.

A substantial number of strokes may be due to underuse of or inadequate anticoagulation in Afib.

The transition process can be challenging for patients and families, requiring a great deal of preplanning by providers.

The International League Against Epilepsy has revised its epilepsy classification system in an effort to inform epilepsy research and aid drug development.

In patients with impaired sensory discrimination, pain descriptors, localization, and pain triggers are often vague or poorly defined.

Up to 20% of stroke cases in young adults occur in those with cervical artery dissection, the leading cause of stroke in this population.

New evidence on diabetic neuropathy has emerged since the ADA’s last published a position statement in 2005.

A larger percentage of participants receiving CBT plus amitriptyline reached a 50% reduction in migraine frequency during treatment compared with HE plus amitriptyline.

There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.

Ronald Petersen, MD, PhD, discusses the implications of Eli Lilly’s failed solanezumab trial on the future of Alzheimer’s disease research.

Female athletes face a greater incidence of and longer recovery time from concussion compared with males.

Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.

A low dose of dexmedetomidine may reduce the incidence of postoperative delirium in the elderly.

The new guidelines offer guidance on dosing, including reduced starting and maintenance dosing and safety precautions for diagnosing and treating complications.

Keeping abreast of changing payment models and regulations is key to maximizing your practice’s finances.

Michael Privatera, MD, AES president spoke with Neurology Advisor about some of the key topics and presentations slated for this year’s meeting.

The present findings, in combination with those from prior observational research, provide a solid rationale for further randomized trials.

The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology’s 2004 guideline development manual.

The group developed the algorithm through a year-long process of reviewing relevant published data.

Future studies should explore ways to increase ongoing exercise adherence among participants

Key opinion leaders weigh in given recent findings that increased use of therapeutic coma in status epilepticus may not be linked with improved outcomes.

Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.

The 4th World Parkinson Congress takes September 20-23, 2016 in Portland, Oregon.